Continuous brain-derived neurotrophic factor (BDNF) infusion after methylprednisolone treatment in severe spinal cord injury.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001369:Axons / Q000473:pathology; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism / Q000494:pharmacology*; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D005260:Female; D019922:GAP-43 Protein / Q000378:metabolism; D005786:Gene Expression Regulation; D007150:Immunohistochemistry; D008775:Methylprednisolone / Q000378:metabolism / Q000494:pharmacology*; D009995:Osmosis; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013116:Spinal Cord / Q000473:pathology; D013119:Spinal Cord Injuries / Q000473:pathology*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D019208:Brain-Derived Neurotrophic Factor; D019922:GAP-43 Protein; D002795:Choline O-Acetyltransferase; D008775:Methylprednisolone